New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study

20 Feb 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · TREATMENT study · Newly Diagnosed Glioblastoma · Phase 1 · Enrollment 35 · Sponsor: Assistance Publique - Hôpitaux de Paris

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Infectious Disease on 20 Feb 2026. The item focuses on New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study. Open the detail page to review the full original feed content.